Insights into germline genetic screening of breast cancer patients
Re-examination of data from four large studies of the benefits and harms of mammography screening shows that the benefits are more consistent across these studies than previously understood and that all the studies indicate a substantial reduction in breast cancer mortality with screening, according to results presented at the 2013 San Antonio Breast Cancer Symposium ( SABCS ), held Dec. 10–14.
There is widespread debate in academic literature and the media about the absolute benefit of mammography screening, commonly defined as the number of women who must be screened to prevent one breast cancer death. Four major reviews of screening and mortality each paint a different picture, with estimates of the number of women who must be screened ranging from 111 to 2,000, an almost twentyfold difference.
Insights into germline genetic screening of breast cancer patients
Powering equity in cancer care through digital health
Choosing Wisely for young women with breast cancer: Radiotherapy
ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies
Psychological issues in familial cancer
SABCS 2023: Latest breast cancer diagnostics guidelines
Genomic testing: Awareness and effective communication between healthcare professionals and patients
Community-based breast cancer control programme in the Philipines
Initiatives for cancer control in Indonesia